Ironwood Pharmaceuticals Inc

Ownership Transactions Reported by 19 Insiders

Symbol
IRWD on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Summer Street, Suite 2300, Boston, MA

Insiders trading volume in the past year

Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alexander Denner Director, 10%+ Owner $14.2M Sep 15, 2025
Jason Rickard SVP, Chief Operating Officer $4.21M Mar 8, 2023
Edward P. Owens Director $3.15M Jun 2, 2021
Thomas A. MCCOURT Chief Executive Officer, Director $1.48M -$252K -14.5% May 16, 2025
Sravan K. Emany SVP, COO and CFO $1.26M -$44.9K -3.43% Nov 18, 2024
Andrew Davis SVP, Chief Business Officer $1.16M -$21.9K -1.85% Nov 18, 2024
Lawrence S. Olanoff Director $1.02M Jun 2, 2021
Michael Shetzline SVP, CMO, Head-Res&Drug $975K -$72.6K -6.93% Feb 10, 2025
Mark G. Currie Director $570K Jun 10, 2025
Minardo John Chief Legal Officer $336K -$75K -18.2% Aug 11, 2025
Ronald Silver Principal Accounting Officer $233K -$23.6K -9.21% Aug 11, 2025
Andrew Dreyfus Director $212K Jun 10, 2025
Tammi L. Gaskins Chief Commercial Officer $203K -$2.59K -1.26% Aug 11, 2025
Julie McHugh Director $194K Jun 10, 2025
Jon R. Duane Director $177K Jun 10, 2025
Jay Shepard Director $160K Jun 10, 2025
Marla L. Kessler Director $154K Jun 10, 2025
Gregory S. Martini Chief Financial Officer $153K -$22.3K -12.7% Aug 11, 2025
Catherine Moukheibir Director $110K Jun 10, 2025

Recent Insider Transactions by Companies or Individuals for Ironwood Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.